ZimVie rises on plans to sell bone business
** Shares of medtech co ZimVie ZIMV.O rise 41.3% to an
over one-year high of $15.9
** Co says it will sell its spine business to investment
firm HIG Capital for $375 million
** After the sale, ZIMV will only sell dental products
** Co intends to utilize the after-tax proceeds to reduce
debt
** The transaction, approved by ZIMV’s board, is expected to
close in H1 2024
** Including session's move, stock up 52% YTD
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
Recent news on Zimvie
See all newsBrief: ZimVie Announces Completion of its Acquisition by ARCHIMED
Brief: ZimVie Stockholders Vote To Approve Acquisition By Archimed
ZimVie Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: ZimVie Q2 Adjusted EPS USD 0.26
ZimVie Inc expected to post earnings of 21 cents a share - Earnings Preview